BRKR - Bruker Corporation
| Previous Close | 48.52 |
| Open | 48.82 |
| Bid | 48.34 x 800 |
| Ask | 48.35 x 800 |
| Day's Range | 48.25 - 49.35 |
| 52 Week Range | 26.10 - 51.41 |
| Volume | 1,125,628 |
| Avg. Volume | 812,108 |
| Market Cap | 7.582B |
| Beta (3Y Monthly) | 1.46 |
| PE Ratio (TTM) | 41.36 |
| EPS (TTM) | 1.17 |
| Earnings Date | Jul 31, 2019 - Aug 5, 2019 |
| Forward Dividend & Yield | 0.16 (0.33%) |
| Ex-Dividend Date | 2019-05-31 |
| 1y Target Est | 51.42 |
- PR Newswire•3 days ago
Bruker Comments on Block Trade Transaction
BILLERICA, Mass. , July 17, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) has been advised that former board member, Mr. Joerg C. Laukien , has authorized a block sale of Bruker shares as part ...
- Zacks•9 days ago
Illumina (ILMN) Grows on Innovation & International Growth
Illumina (ILMN) is benefiting from sturdy demand for sequencing and array systems as well as consumables and services.
- Zacks•9 days ago
NuVasive (NUVA) Launches Pulse Integrated Technology Platform
The launch of this system is in sync with NuVasive's (NUVA) endeavor to deliver end-to-end solutions that offer predictable clinical and economic outcomes in spine surgery.
- Zacks•10 days ago
Boston Scientific's Global Growth Robust Amid Currency Woe
Boston Scientific (BSX) is currently pinning hopes on a stronger performance in China, backed by the recent approval of SYNERGY in the country.
- Zacks•10 days ago
Has Bruker (BRKR) Outpaced Other Computer and Technology Stocks This Year?
Is (BRKR) Outperforming Other Computer and Technology Stocks This Year?
- Zacks•10 days ago
Medtronic Releases Positive Results of LATERAL Clinical Trial
Positive outcomes prove to be a major breakthrough for Medtronic (MDT) in the growing field of ventricular assist devices.
- Zacks•11 days ago
ResMed (RMD) Rides on Strong SaaS Growth & New Product Suite
ResMed's (RMD) new product menu and an array of strategies are likely to benefit from the sleep-disordered breathing market. This should further drive its short-term performance.
- Zacks•11 days ago
Integra Partners AI-Driven Data Analytics Firm in Wound Care
Integra LifeSciences (IART) expects its partnership with Tissue Analytics to be perfectly strategic as the latter's software solutions automatically derive high quality data from clinical pictures.
- Zacks•11 days ago
Phibro Animal Sees Crucial Progress in ASF Vaccine Development
The identification of a group of peptides and proteins is a remarkable step toward Phibro's (PAHC) development of a solution for ASF.
- Zacks•11 days ago
Fresenius Set for Global Expansion of Research Activities
Fresenius Medical Care (FMS) aims to expand the scope of its clinical research activities through an integration move.
- Zacks•12 days ago
Illumina (ILMN) Hits 52-Week High, Can the Run Continue?
Illumina (ILMN) gains from expansion of its product portfolio and strategic partnership.
- Zacks•12 days ago
CVS Health Banks on Aetna Prospects, Omnicare May Disappoint
CVS Health's (CVS) Aetna integration synergies bode well for the stock.
- Zacks•12 days ago
Boston Scientific to Sell Bead Suit, Make Way for BTG Buyout
The sale of oncology bead products by Boston Scientific (BSX) is expected to be among the last steps undertaken by the company to obtain Federal Trade Commission's approval for BTG buyout.
- Zacks•12 days ago
Here's Why CVS Health (CVS) Should Be in Your Portfolio
Investors' trust continues to be high in CVS Health (CVS), thanks to strength in its PBM business.
- Simply Wall St.•12 days ago
Should We Be Delighted With Bruker Corporation's (NASDAQ:BRKR) ROE Of 20%?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
- PR Newswire•12 days ago
Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC
Acquisition strengthens Bruker's portfolio of high-performance PET molecular imaging solutions ZURICH , Switzerland , July 8, 2019 /PRNewswire/ -- Bruker today announced that it has acquired PMOD Technologies ...
- Zacks•15 days ago
Here's Why Chemed (CHE) Should Remain in Your Portfolio Now
Investors' trust in Chemed (CHE) continues to be high, banking on its sturdy segmental performance.
- Zacks•19 days ago
Here's Why Bruker (BRKR) is a Great Momentum Stock to Buy
Does Bruker (BRKR) have what it takes to be a top stock pick for momentum investors? Let's find out.
- Zacks•22 days ago
The Zacks Analyst Blog Highlights: Universal Display, Bruker, Match, j2 and Ciena
The Zacks Analyst Blog Highlights: Universal Display, Bruker, Match, j2 and Ciena
- Zacks•23 days ago
5 Top Tech Gainers of 1H19
The Technology Select Sector SPDR Fund (XLK) is the leading performer among the S&P 500's 11 sectors year to date.
- Zacks•24 days ago
Here's Why You Should Add Bruker (BRKR) to Your Portfolio
Investor confidence in Bruker stock (BRKR) is high on substantial potential of MALDI Biotyper.
- Zacks•25 days ago
Teleflex (TFX) Shares Down on Respiratory Care Product Recall
Teleflex (TFX) issued a statement saying consumers who own the tampered product should immediately discontinue use and return all affected products.
- Zacks•25 days ago
Bruker (BRKR) Hits a 52-Week High on Solid Growth Drivers
Bruker (BRKR) gains from several crucial product launches and acquisitions.
- Zacks•26 days ago
All You Need to Know About Bruker (BRKR) Rating Upgrade to Strong Buy
Bruker (BRKR) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
